Diadema Partners »

Anaptysbio Inc Common shares owned by Diadema Partners

Quarter-by-quarter ownership of Anaptysbio Inc Common (ANAB) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Anaptysbio Inc Common

Tip: Access up to 7 years of quarterly data

All positions including Anaptysbio Inc Common held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anaptysbio Inc Common by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $101k 3.3k 30.62

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Anaptysbio Inc Common

EcoR1 Capital
Point72 Asset Management
Morgan Stanley
BlackRock
Millennium Management
Vanguard Group
Tang Capital Management
First Light Asset Management
State Street Corporation
Assenagon Asset Management
Sanofi
Palo Alto Investors
Soleus Capital Management
683 Capital Management
Woodline Partners

View all funds holding Anaptysbio Inc Common